NATUF News Alert North Amern Tungsten (NATUF) 0.0350 02/15/2015

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
North Amern Tungsten (NATUF) 0.0350 $NATUF

North American Tungsten Reports Fiscal 2014 Results
Marketwired - Tue Jan 13, 4:42PM CST
North American Tungsten Corporation Ltd. (TSX VENTURE: NTC) ("NTC" or "the Company" announces a net loss of $6.6 million or $0.03 per share for its fiscal year ended September 30, 2014 ("fiscal 2014" significantly improved compared to a net loss of $13.3 million or $0.06 per share for the prior fiscal year ("fiscal 2013" .
NTC.VN: 0.050 (+0.005)

North American Tungsten Extends Loan Agreement With Callidus Capital Corporation
Marketwired - Wed Dec 31, 3:46PM CST
North American Tungsten Corporation Ltd. (TSX VENTURE: NTC) ("NTC" or the "Company" announces an amendment to the $11.0 million loan (the "Callidus Loan" with Callidus Capital Corporation ("Callidus" dated May 15, 2014. The amendment includes additional proceeds of $3.65 million and an extension of the repayment date for the loan balance to May 31, 2016. The Callidus Loan remains repayable on demand and bears interest at 18% per annum with interest payable monthly. Principal repayments of $150,000 per month will continue, with the remaining balance due at maturity. The Callidus Loan is secured by a first charge over substantially all assets of the Company, excluding the Mactung Project and all mining and mineral leases, claims and tenures related thereto.
NTC.VN: 0.050 (+0.005), CBL.TO: 17.79 (+0.11)

North American Tungsten Files Technical Report for Cantung Mine-Life of Mine Extended Beyond 2017
Marketwired - Mon Nov 03, 4:02PM CST
North American Tungsten Corporation Ltd. (TSX VENTURE: NTC) ("NTC" or "the Company" announces that the Company has filed a Technical Report entitled "Technical Report on the Cantung Mine, Northwest Territories, Canada" dated September 19, 2014 (the "Report" . The Report was prepared in compliance with National Instrument 43-101 - Standards for Disclosure for Mineral Projects and may be found under the Company's profile on SEDAR at www.sedar.com.
NTC.VN: 0.050 (+0.005)

Williams Creek Gold Announces Addition to its Board of Directors
Marketwire - Wed Oct 01, 7:03AM CDT
Williams Creek Gold Limited ("Williams Creek Gold" or the "Company" (TSX VENTURE: WCX) is pleased to announce the appointment of Stephen M. Leahy to the Company's Board of Directors.
WCX.VN: 0.070 (-0.040)

North American Tungsten's Mactung Project Receives Regulatory Approval
Marketwire - Tue Sep 09, 6:16PM CDT
North American Tungsten Corporation Ltd. (TSX VENTURE: NTC) ("NTC" or "the Company" announces that the plan to develop the Company's Mactung Project ("Mactung" , a tungsten property in Yukon, has received environmental approval. After a deliberative process which began in 2008, Mactung's positive environmental assessment from the Yukon Environmental and Socio-economic Assessment Board ("Board" has been further certified by the Federal and Yukon Governments. The governments issued Decision Documents which will permit the Company to move forward in the regulatory process.
NTC.VN: 0.050 (+0.005)

North American Tungsten Reports Q3 Fiscal 2014 Results
Marketwire - Fri Aug 22, 4:38PM CDT
North American Tungsten Corporation Ltd. (TSX VENTURE: NTC) ("NTC" or "the Company" announces a net loss of $0.4 million or $0.00 per share for the three months ended June 30, 2014 ("Q3 2014" and a net loss of $2.5 million or $0.01 per share for the nine months ended June 30, 2014. These results are substantially improved compared to a net loss of $6.3 million and a net loss of $13.7 million for the comparable periods in fiscal 2013.
NTC.VN: 0.050 (+0.005)

North American Tungsten Completes Financing With Queenwood Capital Partners II LLC
Marketwire - Wed Jul 02, 4:10PM CDT
North American Tungsten Corporation Ltd. (TSX VENTURE: NTC) ("NTC" or the "Company" announces the completion of an US$12.0 million loan (the "Queenwood II Loan" with Queenwood Capital Partners II LLC ("Queenwood II" , to replace its $12.0 million working capital loan facility (the "Working Capital Loan" with HSBC Bank Canada ("HSBC" which expired June 30, 2014.
NTC.VN: 0.050 (+0.005)

North American Tungsten Announces Results of the February 21, 2014 Annual General and Special Meeting of Shareholders
Marketwire Canada - Fri Feb 21, 4:25PM CST
North American Tungsten Corporation Ltd. (TSX VENTURE:NTC) ("NTC" or "the Company" is pleased to announce the results of the annual and special meeting of the shareholders of the Company held February 21, 2014 in Vancouver BC. At the meeting the shareholders of the Company:
NTC.VN: 0.050 (+0.005)




Scroll down for more posts ▼

Top 10 Most Recent News Articles

LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 36

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 26

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 35

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 37

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 31

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 34

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading

Top 5 Most Recently Viewed Articles

Bank of Canada Considers Interest Rate Cuts Amid Growth Concerns

Updated Category News Views 91

Bank of Canada Considers Possible Rate Cuts Recent discussions reported by the Financial Times reveal that Governor Tiff Macklem of the Bank of Canada has started exploring the possibility of increasing the pace at which interest rates could be cut. This potential shift highlights the Bank's response to growing concerns about the Canadian economy's current dynamics....

Continue Reading
Photonics Market Poised for Massive Growth by 2030

Updated Category News Views 151

Understanding the Photonics Market Growth The photonics industry is on an impressive trajectory, with projections indicating it will grow significantly over the coming years. Experts foresee the market expanding from approximately USD 1,093.96 billion to an astounding USD 1,481.80 billion by 2030, reflecting a compound annual growth rate (CAGR) of around 6.3%. This rapid...

Continue Reading
Brookfield Infrastructure Plans Redemption of Preferred Units

Updated Category News Views 154

Brookfield Infrastructure Announces Series 3 Redemption Plan BROOKFIELD, News - Brookfield Infrastructure Partners L.P. (TSX: BIP.UN; NYSE: BIP) has announced its intention to redeem all outstanding Cumulative Class A Preferred Limited Partnership Units, Series 3 (the “Series 3 Preferred Units”). This strategic decision aims to enhance their portfolio's financial...

Continue Reading
How a $1000 Investment in Enphase Energy Grew to $3200

Updated Category News Views 147

Transforming $1000 into $3200 with Enphase Energy Investing can be a journey filled with uncertainties, but the story of Enphase Energy (NASDAQ: ENPH) reveals a powerful lesson in the potential of financial growth. Over the past five years, Enphase Energy has impressively outperformed many market benchmarks, achieving a remarkable annualized return of 26.49%. At present,...

Continue Reading
Investors Should Pay Attention: Rocket Pharmaceuticals Lawsuit Update

Updated Category News Views 191

The Class Action Lawsuit Against Rocket Pharmaceuticals Recently, investors of Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) have been advised to participate in a class action lawsuit for potential securities fraud. This lawsuit arises from significant concerns over the company's disclosure practices and the impact of leadership decisions on stock performance. If you are an...

Continue Reading